期刊文献+

骨质疏松骨折血清骨钙素和尿脱氧吡啶酚变化的研究 被引量:4

A study on the variation of the level of serum osteocalcin and urine deoxypyridinoline in osteoporosis fracture patients
下载PDF
导出
摘要 目的了解骨质疏松骨折患者在骨折愈合过程中骨代谢的变化,更好地指导临床有效的治疗。方法对80例骨折患者愈合过程中血清骨钙素和尿脱氧吡啶酚变化进行观察。结果骨质疏松性骨折后骨钙素呈增高趋势,可超出正常值范围。第3周达到最高峰,第6周逐渐下降到正常值范围;骨质疏松性骨折后尿脱氧吡啶酚亦呈增高趋势,完全超出正常值范围。第6周达到最高峰,第9周逐渐下降但未完全回复正常范围。结论骨质疏松骨折患者早期骨转换都很活跃,血清骨钙素和尿脱氧吡啶酚均增高,尿脱氧吡啶酚的增高较血清骨钙素的增高显著,骨吸收持续影响较大,骨代谢处于失偶联的状态。若早期能有效地控制骨吸收将有利于加强骨形成的能力,最终有利于缩短骨折愈合时间。 Objective To study the variation of bone metabolism in osteoporosis fracture patients in the course of fracture healing, and find a more effective therapy in clinic. Methods Observe the variation of the level of serum osteocalcin and urine deoxypyridinoline in 80 pathologic fracture patients in the course of fracture healing. Results The serum osteocalcin tends to increase after fracture and is likely to exceed the range of normal value, reaches the peak after three weeks and returns back to the normal range after six weeks; the urine deoxypyridinoline tends to increase after fracture beyond the range of normal value completely, reaches the peak after six weeks, falls to the normal range after nine weeks but cann't recover to the normal range completely. Conclusion The bone transition is very active in the early stage of the pathologic fracture. The level of serum osteocalcin and urine deoxypyridinoline all increase,especially of the serum osteocalcin. The bone absorption has more continuous effort and the bone metabolism is uncoupling. Controlling the bone absorption effectively in early stage will benefit to enhance the ability of bone formation and shorten the healing time finally.
作者 黄柏辉
出处 《中国骨质疏松杂志》 CAS CSCD 2007年第8期556-558,共3页 Chinese Journal of Osteoporosis
关键词 骨质疏松 骨折 血清骨钙素 尿脱氧吡啶酚 Osteoporosis Fracture Serum osteocalcin Urine deoxypyridinoline
  • 相关文献

参考文献11

  • 1Jensen JS,Tondevold E.Mortality after hip fractures.Acta Orthop Scand,1979,50(2):161-167.
  • 2Miller CW.Survival and ambulation following hip fracture.J Bone Joint Surg,1978,60A:930-934.
  • 3Fitts WT,Lehr HB,Schor S,et al.Life expectancy after fracture of the hip.Surg Gynecol Obstet,1959,108(2):7-12.
  • 4Sweet MB,Mendelow A,Kotler MN,et al.Fractured neck of femur:Associated morbidity and mortality.S Afr J Surg,1967,5(3):57-64.
  • 5Magaziner J,Simonsick EM,Kashner TM,et al.Predictors of functional recovery one year following hospital discharge for hip fracture:A prospective study.J Gerontol,1990,45(3):M101-M107.
  • 6Benhamou CL,Tourliere D,Gauvain JB,et al.Calciotropic hormones in elderly people with and without hip fracture.Osteoporos Int,1995,5(1):103-107.
  • 7Akesson K,Vergnaud P,Delmas PD,et al.Serum osteocalcin increases during fracture healing in elderly women with hip fracture.Bone,1995,16(3):427-430.
  • 8Cummings SR.Are patients with hip fractures more osteoporotic?Review of the evidence.Am J Med,1985,78(5):487-494.
  • 9Ivaska KK,Kakonen SM,Gerdhem P,et al.Urinary osteocalcin as a marker of bone metabolism.Clin Chem,2005,51 (2):618-620.
  • 10王学谦.骨质疏松症的实验室检查及其临床意义[J].新医学,2006,37(9):616-619. 被引量:4

二级参考文献22

  • 1周丽珍,向青,刘忠厚.合理使用骨质疏松症诊疗的骨代谢标志物指南(2004年版)[J].中国骨质疏松杂志,2004,10(4):397-404. 被引量:21
  • 2薛延.骨质疏松症的生化诊断[J].中国骨质疏松杂志,1995,1(1):58-62. 被引量:66
  • 3王迪浔,主编.钙、磷代谢及紊乱.病理生理学.北京:人民卫生出版社,1996.240-250.
  • 4Drinka PJ.The importance of parathyroid hormone and vitamin D status in the treatment of osteoporosis and renal insufficiency.J Am Med Dir Assoc,2004,5:382-386.
  • 5Gur A,Colpan L,Cevik R,et al.Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.Clin Biochem,2005,38:66-72.
  • 6Nuti R,Martini G,Valenti R,et al.Vitamin D status and bone turnover in women with a cute hip fracture.Clin Orthop Relat Res,2004,422:208-213.
  • 7Garnero P,Delmas PD.Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metablic bone disease.J Clin Endocrinol Metab,1993,77:1046-1053.
  • 8Davey RA,Morris HA.Effects of dihydrotestrone on osteoblast gene expression in osteopenic ovariectomized rats.Endocr Res,2004,30:361-368.
  • 9Ivaska KK,Kakonen SM,Gerdhem P,et al.Urinary Osteocalcin as a Marker of Bone Metabolism.Clin Chem,2005,51:618-628.
  • 10Akesson K,Kakonen SM,Josefsson PO,et al.Fracture-induced changes in bone turnover:a potential confounder in the use of biochemical markers in osteoporosis.J Bone Miner Metab,2005,23:30-35.

共引文献46

同被引文献49

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部